Hongchun Wu
Suzhou, 215000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
CRISPR/Cas9-mediated generation of a REPS2 knockout human embryonic stem cell line.
Journal: Stem cell research
Published: January 20, 2026
Inhibition of circALPK2 enhances proliferation and therapeutic potential of human pluripotent stem cell-derived cardiomyocytes in myocardial infarction.
Journal: Stem cell research & therapy
Published: September 26, 2024
Generation and characterization of the LINC01405 knockout human embryonic stem cell line.
Journal: Stem cell research
Published: August 13, 2024
Development and disease-specific regulation of RNA splicing in cardiovascular system.
Journal: Frontiers in cell and developmental biology
Published: April 26, 2024
Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy.
Journal: Stem cell research
Published: March 25, 2024
The miR-148/152 family contributes to angiogenesis of human pluripotent stem cell- derived endothelial cells by inhibiting MEOX2.
Journal: Molecular therapy. Nucleic acids
Published: October 18, 2022
Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination.
Journal: Stem cell research
Published: November 28, 2020
CXADR-like membrane protein protects against heart injury by preventing excessive pyroptosis after myocardial infarction.
Journal: Journal of cellular and molecular medicine
Published: April 16, 2020
Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes.
Journal: Theranostics
Published: January 20, 2020
MIR148A family regulates cardiomyocyte differentiation of human embryonic stem cells by inhibiting the DLL1-mediated NOTCH signaling pathway.
Journal: Journal of molecular and cellular cardiology
Published: February 13, 2019
Last Updated: 09/26/2026